Adverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (Pbo) in the COMBI-AD trial

V. G. Atkinson, A. Hauschild, M. Santinami, M. Mandala, V. Chiarion Sileni, J. Larkin, M. S. Nyakas, C. Dutriaux, A. Haydon, L. Mortier, C. Robert, J. Schachter, D. Schadendorf, X. Feng, E. de Jong, B. Mookerjee, R. Kefford, R. Dummer, J. M. Kirkwood, G. V. Long

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Article number1251P
Pages (from-to)viii446
Number of pages1
JournalAnnals of Oncology
Volume29
Issue numberSupplement 8
DOIs
Publication statusPublished - 1 Oct 2018
Event43rd European Society for Medical Oncology Congress (ESMO 2018) - Munich, Germany
Duration: 19 Oct 201823 Oct 2018

Cite this